Published in Lipids Health Dis on March 05, 2016
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med (2006) 18.51
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Diabetes in Asia. Lancet (2009) 5.96
Splanchnic lipolysis in human obesity. J Clin Invest (2004) 3.94
Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab (2010) 3.39
Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring) (2006) 3.29
The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci (2004) 3.20
Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation (2007) 3.20
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J (2002) 2.46
Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38
Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. J Am Coll Cardiol (2013) 2.23
Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart (2011) 2.17
Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clin Nutr (2008) 2.12
Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol (2013) 1.96
Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes (1999) 1.84
Relationship between changes in neck circumference and cardiovascular risk factors. Exp Clin Cardiol (2006) 1.82
Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust (2003) 1.78
Neck circumference positively related with central obesity, overweight, and metabolic syndrome in Chinese subjects with type 2 diabetes: Beijing Community Diabetes Study 4. Diabetes Care (2010) 1.55
Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study. Clin Endocrinol (Oxf) (2013) 1.39
Neck circumference as an independent predictive contributor to cardio-metabolic syndrome. Cardiovasc Diabetol (2013) 1.35
Why are we shaped differently, and why does it matter? Am J Physiol Endocrinol Metab (2008) 1.35
Hip circumference and cardiovascular morbidity and mortality in men and women. Obes Res (2004) 1.29
Relationship between neck circumference and cardiometabolic parameters in HIV-infected and non-HIV-infected adults. Diabetes Care (2011) 1.26
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr (2009) 1.25
Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care (2007) 1.20
Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox". J Am Coll Cardiol (2012) 1.16
Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vascul Pharmacol (2012) 1.11
Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging (2013) 1.04
Report of the National Heart, Lung, and Blood Institute's Working Group on obesity and other cardiovascular risk factors in congenital heart disease. Circulation (2010) 1.03
Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J Am Heart Assoc (2014) 0.93
neck circumference and insulin resistance in Chinese adults: the Cardiometabolic Risk in Chinese (CRC) Study. Diabetes Care (2013) 0.89
Reduction of visceral fat correlates with the decrease in the number of obesity-related cardiovascular risk factors in Japanese with Abdominal Obesity (VACATION-J Study). J Atheroscler Thromb (2012) 0.83
Impact of obesity on outcomes in myocardial infarction combating the "obesity paradox". J Am Coll Cardiol (2011) 0.82
Ectopic fat assessment focusing on cardiometabolic and renal risk. Endocrinol Metab (Seoul) (2014) 0.81